通气公司选择 PMD Device Solutions 的 RespiraSense 设备进行 12-18 个月的 3 项临床研究，以增强通气治疗并改善患者治疗效果。 Ventilation company chooses PMD Device Solutions' RespiraSense device for 3 clinical studies over 12-18 months to enhance ventilation therapy and improve patient outcomes.

一家领先的通气公司选择 PMD Device Solutions 的 RespiraSense 设备用于三项临床研究，旨在增强住院和家庭护理患者的通气治疗。 A leading ventilation company has selected PMD Device Solutions' RespiraSense device for use in three clinical studies aimed at enhancing ventilation therapy for both hospitalized and homecare patients. 这些研究将于未来 12-18 个月内进行，旨在通过连续测量呼吸频率来及时做出临床决策，从而改善患者的治疗结果。 These studies, set to take place over the next 12-18 months, aim to improve patient outcomes by enabling timely clinical decision-making through continuous measurement of respiratory rates. RespiraSense 已被现有的医院和家庭护理临床团队实施，以针对每位患者的特定需求优化治疗。 RespiraSense has already been implemented by existing hospital and homecare clinical teams to optimize therapy for each patient's specific needs.